Overview

• Truemeds raised $85 million in a new round led by Accel, with Peak XV Partners, WestBridge Capital and InfoEdge Ventures also participating.
• The fresh injection lifted its valuation to over $400 million, up from $110 million in its 2023 round.
• It achieved 66% revenue growth to ₹5 billion in the past year, serving 500,000 monthly active users with over 15% revenue retention after 12 months.
• The company plans to allocate at least 20% of the new capital to engineering and product development while opening a Bengaluru technology hub.
• Truemeds will triple its fulfillment centers and pilot diagnostics services in tier-2 cities to deepen its reach beyond metros.